DE69003652T2 - Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen. - Google Patents
Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen.Info
- Publication number
- DE69003652T2 DE69003652T2 DE90906552T DE69003652T DE69003652T2 DE 69003652 T2 DE69003652 T2 DE 69003652T2 DE 90906552 T DE90906552 T DE 90906552T DE 69003652 T DE69003652 T DE 69003652T DE 69003652 T2 DE69003652 T2 DE 69003652T2
- Authority
- DE
- Germany
- Prior art keywords
- aliphatic alcohols
- flammable
- treatment
- skin diseases
- viral skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/345,084 US4874794A (en) | 1989-04-28 | 1989-04-28 | Inflammatory disease treatment |
PCT/US1990/002045 WO1990013216A2 (en) | 1989-04-28 | 1990-04-16 | Inflammatory disease treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69003652D1 DE69003652D1 (de) | 1993-11-04 |
DE69003652T2 true DE69003652T2 (de) | 1994-03-24 |
Family
ID=23353439
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE90906552T Expired - Lifetime DE69003652T2 (de) | 1989-04-28 | 1990-04-16 | Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen. |
DE122007000080C Active DE122007000080I2 (de) | 1989-04-28 | 1990-04-16 | Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE122007000080C Active DE122007000080I2 (de) | 1989-04-28 | 1990-04-16 | Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4874794A (de) |
EP (1) | EP0428642B1 (de) |
JP (1) | JPH03505882A (de) |
AT (1) | ATE95060T1 (de) |
DE (2) | DE69003652T2 (de) |
DK (1) | DK0428642T3 (de) |
ES (1) | ES2060158T3 (de) |
HK (1) | HK120497A (de) |
NL (1) | NL300354I2 (de) |
WO (1) | WO1990013216A2 (de) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5370871A (en) * | 1983-01-24 | 1994-12-06 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US5380754A (en) * | 1988-02-29 | 1995-01-10 | Virotex Corporation | Topical composition enhancing healing of viral lesions |
US5135956A (en) * | 1988-10-18 | 1992-08-04 | The Regents Of The University Of California | Method of using cytoprotective alcohols to treat neural disease and neural injury |
CA2044162A1 (fr) * | 1989-10-13 | 1991-04-14 | Jacques Borg | Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophes et cytoprotectrices, et compositions pharmaceutiques les contenant |
US5296514A (en) * | 1991-04-23 | 1994-03-22 | Summit Technology, Inc. | Corneal treatment agents |
US5098896A (en) * | 1991-04-23 | 1992-03-24 | Summit Technology, Inc. | Corneal treatment agents |
US5214071A (en) * | 1991-04-23 | 1993-05-25 | Summit Technology, Inc. | Corneal treatment agents |
US5198217A (en) * | 1991-09-24 | 1993-03-30 | Choice Pharmaceuticals | Topical demulcent for viral and inflammatory diseases of the skin |
CN1103586C (zh) * | 1993-12-13 | 2003-03-26 | 里达克药品公司 | 蔗糖酯-c20-28醇制剂 |
US6440980B1 (en) * | 1996-09-17 | 2002-08-27 | Avanir Pharmaceuticals | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
US5952392A (en) * | 1996-09-17 | 1999-09-14 | Avanir Pharmaceuticals | Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition |
US5948822A (en) * | 1996-12-17 | 1999-09-07 | Lidak Pharmaceuticals | Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols |
US20050203187A1 (en) * | 1998-06-01 | 2005-09-15 | Verbiscar Anthony J. | Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof |
ATE298345T1 (de) | 1999-09-03 | 2005-07-15 | Cabby Business Inc | Effizientes verfahren zur herstellung sehr reiner sterinen |
US8173709B2 (en) * | 1999-09-22 | 2012-05-08 | Quadex Pharmaceuticals, Llc | Anti-infective methods for treating pathogen-induced disordered tissues |
PT102410A (pt) * | 2000-02-03 | 2001-08-30 | Qualitas Lab | Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico |
EP1272160B1 (de) * | 2000-04-12 | 2007-01-17 | Liplasome Pharma A/S | Auf lipiden basierende arzneistoffabgabesysteme zur topischen anwendung |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
WO2003032915A2 (en) * | 2001-10-16 | 2003-04-24 | Avanir Pharmacueticals | Viral inhibition by n-docosanol |
DE10203688A1 (de) | 2002-01-31 | 2003-08-07 | Bayer Cropscience Ag | Synergistische insektizide Mischungen |
DE10207242A1 (de) * | 2002-02-21 | 2003-09-04 | Bayer Cropscience Ag | Synergistische insektizide Mischungen |
US7214394B2 (en) * | 2002-05-31 | 2007-05-08 | Archer-Daniels-Midland Company | Policosanol compositions, extraction from novel sources, and uses thereof |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
MXPA05004278A (es) | 2002-10-25 | 2005-10-05 | Foamix Ltd | Espuma cosmetica y farmaceutica. |
US8119150B2 (en) * | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US7645803B2 (en) | 2005-05-09 | 2010-01-12 | Foamix Ltd. | Saccharide foamable compositions |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
BRPI0412975A (pt) | 2003-08-25 | 2006-10-03 | Foamix Ltd | espuma penetrante para uso farmacêutico |
US20050074443A1 (en) * | 2003-10-03 | 2005-04-07 | Treadwell Benjamin V. | Methods of attenuating autoimmune disease and compositions useful therefor |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
EP2242476A2 (de) | 2008-01-14 | 2010-10-27 | Foamix Ltd. | Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen |
US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
MX359879B (es) | 2009-10-02 | 2018-10-12 | Foamix Pharmaceuticals Ltd | Composiciones tópicas de tetraciclina. |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US8470880B2 (en) | 2009-12-15 | 2013-06-25 | Mcneil-Ppc, Inc. | Methods of reducing hair loss and/or facilitating hair growth and/or regrowth |
US8470833B2 (en) | 2009-12-15 | 2013-06-25 | Mcneil-Ppc, Inc. | Hair growth and/or regrowth compositions |
WO2011112997A1 (en) | 2010-03-11 | 2011-09-15 | Chemic Laboratories, Inc. | Novel compositions and methods |
US8846725B2 (en) | 2011-01-24 | 2014-09-30 | Quadex Pharmaceuticals, Llc | Highly penetrating compositions and methods for treating pathogen-induced disordered tissues |
US9549930B2 (en) | 2013-03-14 | 2017-01-24 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered and/or prodromal stage tissue |
US9125911B2 (en) | 2013-03-14 | 2015-09-08 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered tissues |
US9463180B2 (en) | 2013-03-14 | 2016-10-11 | Quadex Pharmaceuticals, Llc | Treatment of molluscum contagiosum |
US9675537B2 (en) | 2014-06-30 | 2017-06-13 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
US20180235984A1 (en) | 2015-08-20 | 2018-08-23 | Foamix Pharmaceuticals Ltd. | Tetracycline management of egfr inhibitor associated dermatoses |
US11666520B2 (en) | 2015-12-28 | 2023-06-06 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
WO2021022056A1 (en) | 2019-07-31 | 2021-02-04 | Foamix Pharmaceuticals Ltd. | Compositions and methods and uses thereof |
IL294239A (en) | 2019-12-31 | 2022-08-01 | Vyne Therapeutics Inc | A topical preparation that includes topacitinib and fingolimod |
-
1989
- 1989-04-28 US US07/345,084 patent/US4874794A/en not_active Expired - Lifetime
-
1990
- 1990-04-16 JP JP2506223A patent/JPH03505882A/ja active Pending
- 1990-04-16 WO PCT/US1990/002045 patent/WO1990013216A2/en active IP Right Grant
- 1990-04-16 EP EP90906552A patent/EP0428642B1/de not_active Expired - Lifetime
- 1990-04-16 ES ES90906552T patent/ES2060158T3/es not_active Expired - Lifetime
- 1990-04-16 DK DK90906552.6T patent/DK0428642T3/da active
- 1990-04-16 DE DE90906552T patent/DE69003652T2/de not_active Expired - Lifetime
- 1990-04-16 DE DE122007000080C patent/DE122007000080I2/de active Active
- 1990-04-16 AT AT90906552T patent/ATE95060T1/de active
-
1997
- 1997-06-26 HK HK120497A patent/HK120497A/xx not_active IP Right Cessation
-
2008
- 2008-06-05 NL NL300354C patent/NL300354I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
NL300354I1 (nl) | 2008-08-01 |
HK120497A (en) | 1997-09-05 |
NL300354I2 (nl) | 2008-10-01 |
WO1990013216A2 (en) | 1990-11-15 |
EP0428642B1 (de) | 1993-09-29 |
EP0428642A1 (de) | 1991-05-29 |
DK0428642T3 (da) | 1994-02-21 |
JPH03505882A (ja) | 1991-12-19 |
DE122007000080I2 (de) | 2008-11-06 |
ATE95060T1 (de) | 1993-10-15 |
DE69003652D1 (de) | 1993-11-04 |
DE122007000080I1 (de) | 2008-02-28 |
US4874794A (en) | 1989-10-17 |
ES2060158T3 (es) | 1994-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69003652T2 (de) | Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen. | |
DE3752045T2 (de) | Verwendung von Hydroxycarbonsäuren und Derivaten zur Herstellung topischer dermatologischer Zubereitungen zur Behandlung von Falten | |
ATE19924T1 (de) | Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der humanund veterinaermedizin. | |
DE3674170D1 (de) | Verband fuer die behandlung von wunden und herstellungsverfahren. | |
DE69224124T2 (de) | Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid | |
ATE116848T1 (de) | Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris. | |
DE3683333D1 (de) | Mittel zur behandlung von akne vulgaris und deren herstellung. | |
DE3750934T2 (de) | Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten. | |
ATE106754T1 (de) | Verfahren zur herstellung von rinder-pericard- materialien und ihre verwendung. | |
JPS6423842A (en) | Method for allowing pulmonary respiration animal to be slaughtered to swoon | |
ATE7107T1 (de) | Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln. | |
NO175885C (no) | Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling | |
ATE143804T1 (de) | Zusammensetzung zur behandlung von mastitis und metritis | |
ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
DE69004425T2 (de) | Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen. | |
PT86552A (de) | Gama-glutamyl-transpeptidase deren herstellung und deren verwendung | |
DE59002154D1 (de) | Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe. | |
ATE115863T1 (de) | Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen. | |
ATE30114T1 (de) | Mittel zur pflege oder behandlung der menschlichen haut. | |
JPS5531001A (en) | Preparation of beauty wash composed of natural lemon and pure honey | |
DE3674213D1 (de) | Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung. | |
ATE69949T1 (de) | Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
ATE453T1 (de) | N-cyclohexyl-n-methoxyacetoacetamid, verfahren zu seiner herstellung und seine verwendung zur herstellung von o-methyln-cyclohexyl-2,5-dimethylfuran-3-hydroxamsaeure. | |
DE58901297D1 (de) | Noremopamil, seine herstellung und verwendung. | |
ATE129636T1 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
V448 | Application of spc |
Free format text: PRODUCT NAME: DOCOSAN-1-OL; REGISTRATION NO/DATE: 67648.00.00, 20070810 Spc suppl protection certif: 12 2007 000 080 Filing date: 20071121 |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: AVANIR PHARMACEUTICALS CORPORATION, LA JOLLA, , US |
|
V484 | Delivery of the decision of grant |
Free format text: PRODUCT NAME: DOCOSAN-1-OL; REGISTRATION NO/DATE: 67648.00.00, 20070810 Spc suppl protection certif: 12 2007 000 080 Filing date: 20071121 |
|
V457 | Spc granted |
Free format text: PRODUCT NAME: DOCOSAN-1-OL; REGISTRATION NO/DATE: 67648.00.00, 20070810 Spc suppl protection certif: 12 2007 000 080 Filing date: 20071121 |
|
R081 | Change of applicant/patentee |
Owner name: ENGELHARD ARZNEIMITTEL GMBH & CO. KG, DE Free format text: FORMER OWNER: AVANIR PHARMACEUTICALS, ALISO VIEJO, US Spc suppl protection certif: 122007000080 Filing date: 20071121 Expiry date: 20100417 Extension date: 20150416 |
|
R082 | Change of representative |
Free format text: PRODUCT NAME: DOCOSAN-1-OL; NAT. REGISTRATION NO/DATE: 67648.00.00 20070810; FIRST REGISTRATION: SE18517 20031114 Spc suppl protection certif: 122007000080 Filing date: 20071121 Expiry date: 20100417 Representative=s name: WITTE, WELLER & PARTNER PATENTANWAELTE MBB, DE Extension date: 20150416 |
|
R071 | Expiry of right |
Free format text: PRODUCT NAME: DOCOSAN-1-OL; NAT. REGISTRATION NO/DATE: 67648.00.00 20070810; FIRST REGISTRATION: SE18517 20031114 Spc suppl protection certif: 122007000080 Filing date: 20071121 Expiry date: 20100417 Extension date: 20150416 Effective date: 20150417 |